Article Text

Download PDFPDF

5PSQ-080 Clinical interventions in patients undergoing anti-Parkinsonian treatment: the importance of correct reconciliation
Free
  1. E Paradela García,
  2. I Corriente,
  3. M Florido Francisco,
  4. R Serrano
  1. Juan Ramon Jimenez University Hospital, Hospital Pharmacy, Huelva, Spain

Abstract

Background and Importance The purpose of the anti-Parkinsonian pharmacological treatment is to optimise dopamine levels and control of disease symptoms. Therefore, it is essential to implement a correct reconciliation procedure at hospitalisation to avoid adverse effects associated with the medication.1 2

Aim and Objectives To describe the interventions performed in hospitalised patients undergoing anti-Parkinsonian treatment, by hospital pharmacists in the area of pharmaceutical validation, and to evaluate their acceptance degree by clinicians.

Material and Methods This was a prospective, single-centre and interventional study, conducted from September 2022 to September 2023. The study included all the hospitalised patients showing a discordance between their domiciliary anti-Parkinsonian treatment and at hospitalisation. Demographic (sex, age), clinical [clinical judgements(CJ) and inpatient clinical service] and pharmacotherapeutic [number of chronic medicines and polymedication (≥6 drugs)] variables were collected. Interventions were reported to clinician via e-prescribing software. They were classified into: adequacy (detection of prescribing error/therapy reconciliation error), initiation (usual treatment not prescribed), posology modification (dosage increase/decrease, frequency/schedule modification), suspension (duplicity/unnecessary medication). Patient lists and data were collected through medical records and e-prescribing software, and processed using LibreOffice spreadsheet-7.5.1.2®.

Results The study included 34 patients (64.7% male; 35.3% female; median age 76 years; IQR=84–71). Most frequent CJ: urinary infection (11.8%), surgical intervention (11.8%) and deterioration of general condition (8.8%). Inpatient clinical services: Internal Medicine (47.1%), Gastroenterology (17.6%), Urology (5.9%), Cardiology (5.9%), Pneumology (5.9%) and Traumatology (5.9%). The median number of active medications was 11 (IQR=11–8). Polymedicated patients raised up to 85.3%. The number of interventions performed was 60 (n=12 ‘not accepted’ because of discharge/non-acceptance by the clinician). With regard to those accepted (n=48), 8.3% related to adequacy (4.2% detection of prescribing error, 4.2% therapy reconciliation error), 4.2% related to initiation (usual treatment not prescribed), 58.3% related to posology modification (27.1% dosage increase/decrease, 31.2% frequency/schedule modification) and 29.2% to suspension (2.1% duplicity and 27.1% prescription of unnecessary medication). Most interventions affected levodopa/carbidopa treatment but other medications represented a reduced percentage (10%) (safinamide, levodopa/benserazide or rasagiline).

Conclusion and Relevance The supervision of Parkinsonian patients at hospitalisation is a pharmaceutical daily work. This study showed that the reconciliation procedure has a high degree of acceptance, improving the quality and safety of the therapy.

References and/or Acknowledgements 1. https://neurologia.com/articulo/2022217/eng

2. https://pubmed.ncbi.nlm.nih.gov/24389262/

Conflict of Interest No conflict of interest.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.